Patterns of response with talimogene laherparepvec in combination with ipilimumab or ipilimumab alone in metastatic unresectable melanoma

Talimogene laherparepvec (T-VEC) has demonstrated efficacy for unresectable melanoma. We explored response patterns from a phase 2 study evaluating patients with unresectable stage IIIB–IVM1c malignant melanoma who received T-VEC plus ipilimumab or ipilimumab alone. Patients with objective response...

Descripción completa

Detalles Bibliográficos
Autores principales: Chesney, Jason, Puzanov, Igor, Collichio, Frances, Milhem, Mohammed M., Hauschild, Axel, Chen, Lisa, Sharma, Anjali, Garbe, Claus, Singh, Parminder, Mehnert, Janice M.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group UK 2019
Materias:
Brief Communication
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6738060/
https://www.ncbi.nlm.nih.gov/pubmed/31353364
http://dx.doi.org/10.1038/s41416-019-0530-6

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6738060/
https://www.ncbi.nlm.nih.gov/pubmed/31353364
http://dx.doi.org/10.1038/s41416-019-0530-6

Ejemplares similares